| 翻訳と辞書 |
| Cordis (medical) ： ウィキペディア英語版 |
Cordis (medical)
Cordis Corporation develops and manufacturers diagnostic and interventional products to treat patients who suffer from coronary and peripheral vascular diseases. It was founded in 1959 in Miami, Florida. Cordis Corporation is a company of Cardinal Health. The Cordis global headquarters and a Europe, Middle East and Africa hub are located in Zug, Switzerland. North American operations are based out of the San Francisco Bay area. The Asia-Pacific hub is located in Singapore, and the Latin American hub is located in Puerto Rico.
== History ==
The Medical Development Corporation was founded in 1957 in Miami, Florida, by Dr. William P. Murphy Jr. and focused on interventional vascular medicine and neuroscience. In 1959 the company’s name changed to Cordis. Cordis joined the Johnson & Johnson interventional business called “Johnson & Johnson Intervention Systems (JJIS)” and forms Cordis Corporation in 1996. In 1997 Cordis Corporation expanded into the rapidly growing field of electrophysiology through the acquisition of Biosense Inc. One year later, in 1998, Biosense Inc. merged with Webster Laboratories to form Biosense Webster, Inc.
On October 4, 2015, Cardinal Health announced that it has completed the acquisition of Johnson & Johnson's Cordis business for $1.944 billion.〔http://www.prnewswire.com/news-releases/cardinal-health-completes-acquisition-of-cordis-300153418.html#〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Cordis (medical)」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|